RPG Active Pharma acquires API business of Raghava Life Sciences to strengthen its integrated API…
RPG Life Sciences announced that its wholly owned subsidiary, RPG Active Pharma (RPGAP), has entered into a Business Transfer…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
API
Patent pause: Link extensions to pendency
India is now well-positioned to introduce a limited, risk-calibrated patent-term extension (PTE) mechanism tailored to Active…
HRV Pharma, Shodhana partner to accelerate next-gen API development
HRV Pharma, India's first integrated Virtual API and Pharmtech company announced a comprehensive, multi-year Contract Development…
Supriya Lifescience ramps up capacity and global readiness for next phase of growth
Supriya Lifescience has built a strong global presence in Active Pharmaceutical Ingredients. What has guided this journey?
Our…
Separate license regime for bulk drugs, API and KSMs, under govt’s consideration
The government is considering a separate licensing framework for bulk drugs, active pharmaceutical ingredients (APIs) and key…
HRV Pharma and MetroChem forge strategic CDMO alliance
HRV Global Life Sciences (HRV Pharma), India’s first integrated Virtual API and Pharmtech company, announced a unique,…
Lilly to build $6.5 billion API manufacturing facility in Texas
Eli Lilly and Company has announced its plan to build a new $6.5 billion manufacturing facility at Generation Park in Houston,…
Aparna Pharmaceuticals secures EUGMP certification for Pydibhimavaram facility
Aparna Pharmaceuticals, a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and Advanced Drug Intermediates,…
Lilly partners with API to launch a CME for obesity
The Obesity Gurukul program will aim to offer a structured and immersive learning experience for over 20,000 healthcare…
Alembic Pharmaceuticals receives USFDA EIR for API-III facility in Gujarat
The inspection at the Karakhadi-based manufacturing site was conducted by the USFDA from 17 to 21 March 2025